scholarly journals The Non-Anhydrous, Minimally Basic Synthesis of the Dopamine D2 Agonist [18F]MCL-524

Chemistry ◽  
2021 ◽  
Vol 3 (3) ◽  
pp. 1047-1056
Author(s):  
James A. H. Inkster ◽  
Anna W. Sromek ◽  
Vamsidhar Akurathi ◽  
John L. Neumeyer ◽  
Alan B. Packard

The dopamine D2 agonist MCL-524 is selective for the D2 receptor in the high-affinity state (D2high), and, therefore, the PET analogue, [18F]MCL-524, may facilitate the elucidation of the role of D2high in disorders such as schizophrenia. However, the previously reported synthesis of [18F]MCL-524 proved difficult to replicate and was lacking experimental details. We therefore developed a new synthesis of [18F]MCL-524 using a “non-anhydrous, minimally basic” (NAMB) approach. In this method, [18F]F− is eluted from a small (10–12 mg) trap-and-release column with tetraethylammonium tosylate (2.37 mg) in 7:3 MeCN:H2O (0.1 mL), rather than the basic carbonate or bicarbonate solution that is most often used for [18F]F− recovery. The tosylated precursor (1 mg) in 0.9 mL anhydrous acetonitrile was added directly to the eluate, without azeotropic drying, and the solution was heated (150 °C/15 min). The catechol was then deprotected with the Lewis acid In(OTf)3 (10 equiv.; 150 °C/20 min). In contrast to deprotection with protic acids, Lewis-acid-based deprotection facilitated the efficient removal of byproducts by HPLC and eliminated the need for SPE extraction prior to HPLC purification. Using the NAMB approach, [18F]MCL-524 was obtained in 5–9% RCY (decay-corrected, n = 3), confirming the utility of this improved method for the multistep synthesis of [18F]MCL-524 and suggesting that it may applicable to the synthesis of other 18F-labeled radiotracers.

1994 ◽  
Vol 55 (6) ◽  
pp. 1125-1130 ◽  
Author(s):  
Shuji Aou ◽  
Masaharu Mizuno ◽  
Tetsuro Hori ◽  
Katsushi Yamada

Life Sciences ◽  
1994 ◽  
Vol 54 (14) ◽  
pp. 957-966 ◽  
Author(s):  
Naoyuki Todo ◽  
Toshihiko Momiyama ◽  
Taku Amano ◽  
Yasuko Kohno ◽  
Masashi Sasa

2006 ◽  
Vol 27 (1) ◽  
pp. 88
Author(s):  
Sa Yong Kim ◽  
Kyu seok Kim ◽  
Seung Woo Shin ◽  
Min Sun Kim ◽  
Ja Hyun Baik

1994 ◽  
Vol 64 ◽  
pp. 172
Author(s):  
Nobuhiko Arai ◽  
Masayuki Isaji ◽  
Hiroshi Miyata ◽  
Eiji Mizuta ◽  
Sadako Kuno

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Mi-Hyun Choi ◽  
Ji Eun Na ◽  
Ye Ran Yoon ◽  
Hyo Jin Lee ◽  
Sehyoun Yoon ◽  
...  

2020 ◽  
Vol 237 (9) ◽  
pp. 2855-2872
Author(s):  
E.A Boonstra ◽  
M.R van Schouwenburg ◽  
A.K Seth ◽  
M Bauer ◽  
J.B Zantvoord ◽  
...  

Abstract Rationale Conscious perception is thought to depend on global amplification of sensory input. In recent years, striatal dopamine has been proposed to be involved in gating information and conscious access, due to its modulatory influence on thalamocortical connectivity. Objectives Since much of the evidence that implicates striatal dopamine is correlational, we conducted a double-blind crossover pharmacological study in which we administered cabergoline—a dopamine D2 agonist—and placebo to 30 healthy participants. Under both conditions, we subjected participants to several well-established experimental conscious-perception paradigms, such as backward masking and the attentional blink task. Results We found no evidence in support of an effect of cabergoline on conscious perception: key behavioral and event-related potential (ERP) findings associated with each of these tasks were unaffected by cabergoline. Conclusions Our results cast doubt on a causal role for dopamine in visual perception. It remains an open possibility that dopamine has causal effects in other tasks, perhaps where perceptual uncertainty is more prominent.


Sign in / Sign up

Export Citation Format

Share Document